PUBLISHER: Value Market Research | PRODUCT CODE: 1475207
PUBLISHER: Value Market Research | PRODUCT CODE: 1475207
The global demand for Parenteral Packaging Market is presumed to reach the market size of nearly USD 25.89 Billion by 2032 from USD 10.21 Billion in 2023 with a CAGR of 10.89% under the study period 2024 - 2032.
Parenteral packaging refers to the materials and containers used for the sterile packaging injectable drugs, fluids, and solutions intended for administration via routes other than the digestive tract, such as intravenous, intramuscular, or subcutaneous injection. These packaging systems must maintain the sterility, integrity, and stability of the pharmaceutical product throughout its shelf life, protecting it from contamination, light exposure, and physical damage. Common parenteral packaging materials include glass vials, ampules, syringes, and pre-filled cartridges, as well as plastic containers and bags made from materials such as polypropylene, polyethylene, and cyclic olefin copolymer (COC).
The growing prevalence of chronic diseases, aging populations, and advancements in biopharmaceuticals drive the demand for parenteral medications administered via injection routes such as subcutaneous (SC) injections and intravenous (IV). With rising healthcare expenditures, expanding patient populations, and the increasing adoption of injectable therapies for cancer, diabetes, autoimmune diseases, and infectious diseases, there is a growing need for parenteral packaging solutions that ensure product integrity, compatibility, and patient safety throughout the drug lifecycle. Additionally, advancements in packaging materials, container closure systems, and sterile manufacturing processes enable the development of parenteral packaging solutions that offer barrier protection, microbial stability, and tamper-evident features to maintain drug potency, stability, and sterility during storage, transportation, and administration.
Moreover, the increasing emphasis on patient-centric packaging, user-friendly designs, and compliance packaging drives market innovation as pharmaceutical companies seek packaging solutions that enhance medication adherence, facilitate self-administration, and improve patient outcomes. Furthermore, regulatory requirements, quality standards, and industry guidelines for parenteral packagings, such as USP <797>, USP <800>, and ISO 13485, drive market compliance, quality assurance, and product differentiation as manufacturers strive to meet regulatory expectations, mitigate risks, and maintain product safety and efficacy. However, stringent regulatory requirements, safety standards, and compliance issues may hamper market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of parenteral packaging. The growth and trends of parenteral packaging industry provide a holistic approach to this study.
This section of the parenteral packaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Parenteral Packaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Packaging market include RPC Group, Unilife Corporation, Gerresheimer AG, Stevanato Group, Berry Plastics Corporation, Nipro Corporation, MeadWestvaco Corporation, Becton Dickinson and Company Inc., Schott AG, Dickinson and Company Inc., Ypsomed Holding AG, Terumo Corporation, SiO2 Medical Products, West Pharmaceutical Services, Schott Pharmaceuticals Services Inc., Owens-Illinois, Graphic Packaging Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.